PH12014502686A1 - Differentiation of human embryonic stem cells into pancreatic endoderm - Google Patents
Differentiation of human embryonic stem cells into pancreatic endodermInfo
- Publication number
- PH12014502686A1 PH12014502686A1 PH12014502686A PH12014502686A PH12014502686A1 PH 12014502686 A1 PH12014502686 A1 PH 12014502686A1 PH 12014502686 A PH12014502686 A PH 12014502686A PH 12014502686 A PH12014502686 A PH 12014502686A PH 12014502686 A1 PH12014502686 A1 PH 12014502686A1
- Authority
- PH
- Philippines
- Prior art keywords
- differentiation
- stem cells
- pancreatic endoderm
- embryonic stem
- human embryonic
- Prior art date
Links
- 230000004069 differentiation Effects 0.000 title abstract 2
- 210000001671 embryonic stem cell Anatomy 0.000 title 1
- 210000001900 endoderm Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000004039 endoderm cell Anatomy 0.000 abstract 1
- 238000010899 nucleation Methods 0.000 abstract 1
- 210000001778 pluripotent stem cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/005—Protein-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0678—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
- C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/065—Modulators of histone acetylation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/19—Growth and differentiation factors [GDF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2511/00—Cells for large scale production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261643684P | 2012-05-07 | 2012-05-07 | |
| PCT/US2013/039940 WO2013169769A1 (en) | 2012-05-07 | 2013-05-07 | Differentiation of human embryonic stem cells into pancreatic endoderm |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12014502686A1 true PH12014502686A1 (en) | 2015-01-26 |
Family
ID=49551213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12014502686A PH12014502686A1 (en) | 2012-05-07 | 2014-12-02 | Differentiation of human embryonic stem cells into pancreatic endoderm |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20140162359A1 (enExample) |
| EP (1) | EP2847319A4 (enExample) |
| JP (1) | JP6450674B2 (enExample) |
| KR (1) | KR20150014478A (enExample) |
| CN (1) | CN104284977A (enExample) |
| AR (1) | AR090970A1 (enExample) |
| AU (1) | AU2013259706A1 (enExample) |
| BR (1) | BR112014027783A2 (enExample) |
| CA (1) | CA2872770A1 (enExample) |
| HK (1) | HK1207885A1 (enExample) |
| IL (1) | IL235132A0 (enExample) |
| IN (1) | IN2014DN08561A (enExample) |
| MX (1) | MX2014013524A (enExample) |
| PH (1) | PH12014502686A1 (enExample) |
| RU (1) | RU2668814C2 (enExample) |
| SG (1) | SG11201406884SA (enExample) |
| WO (1) | WO2013169769A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3008170A4 (en) | 2013-06-11 | 2016-11-09 | Harvard College | SC-CELLS AND COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF |
| ES2985135T3 (es) | 2014-12-18 | 2024-11-04 | Harvard College | Procedimientos para generar células ß derivadas de células madre y usos de las mismas |
| CN107614678B (zh) | 2014-12-18 | 2021-04-30 | 哈佛学院校长同事会 | 干细胞来源的β细胞的产生方法及其使用方法 |
| US10443042B2 (en) | 2014-12-18 | 2019-10-15 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof |
| CN106467918B (zh) * | 2015-08-18 | 2020-07-31 | 中国科学技术大学先进技术研究院 | 一种基于人皮肤细胞的胰岛素分泌细胞的诱导方法及应用 |
| CN111094547B (zh) * | 2017-06-14 | 2024-02-09 | 德国亥姆霍兹慕尼黑中心健康与环境研究中心（有限公司） | 用于纯化源自人胚胎干细胞的内胚层和胰腺内胚层细胞的方法 |
| CA3081762A1 (en) | 2017-11-15 | 2019-05-23 | Semma Therapeutics, Inc. | Islet cell manufacturing compositions and methods of use |
| CA3108275A1 (en) | 2018-08-10 | 2020-02-13 | Vertex Pharmaceuticals Incorporated | Stem cell derived islet differentiation |
| US12378572B2 (en) | 2018-09-07 | 2025-08-05 | Crispr Therapeutics Ag | Universal donor cells |
| AU2020283150B2 (en) | 2019-05-31 | 2023-08-17 | Viacyte, Inc. | Cell encapsulation devices with controlled oxygen diffusion distances |
| AU2020283056B2 (en) | 2019-05-31 | 2023-06-08 | Viacyte, Inc. | A biocompatible membrane composite |
| US20220234006A1 (en) | 2019-05-31 | 2022-07-28 | W. L. Gore & Associates, Inc. | A biocompatible membrane composite |
| US20220233298A1 (en) | 2019-05-31 | 2022-07-28 | W. L. Gore & Associates, Inc. | A biocompatible membrane composite |
| EP4025690A1 (en) | 2019-09-05 | 2022-07-13 | CRISPR Therapeutics AG | Universal donor cells |
| BR112022004031A2 (pt) | 2019-09-05 | 2022-08-16 | Crispr Therapeutics Ag | Células doadoras universais |
| US11578309B2 (en) | 2020-12-31 | 2023-02-14 | Crispr Therapeutics Ag | Universal donor cells |
| CN113046306B (zh) * | 2021-03-12 | 2022-10-18 | 广东东阳光药业有限公司 | 一种多能干细胞的培养方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5523226A (en) * | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
| CA2692325C (en) | 2001-12-07 | 2015-10-20 | Geron Corporation | Islet cells from human embryonic stem cells |
| CN103898047B (zh) | 2003-12-23 | 2020-03-03 | 维亚希特公司 | 定形内胚层 |
| US20050266554A1 (en) | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
| US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
| US8741643B2 (en) * | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
| AU2007277364B2 (en) | 2006-07-26 | 2010-08-12 | Viacyte, Inc. | Methods of producing pancreatic hormones |
| ES2626656T3 (es) * | 2007-07-01 | 2017-07-25 | Lifescan, Inc. | Cultivo de célula madre pluripotente individual |
| PL2185695T3 (pl) * | 2007-07-18 | 2015-08-31 | Lifescan Inc | Różnicowanie ludzkich zarodkowych komórek macierzystych |
| CA3207103A1 (en) * | 2007-07-31 | 2009-02-05 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to pancreatic endocrine |
| US7939322B2 (en) * | 2008-04-24 | 2011-05-10 | Centocor Ortho Biotech Inc. | Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm |
| BRPI0914116A2 (pt) * | 2008-06-30 | 2019-09-17 | Centocor Ortho Biotech Inc | diferenciação de células-tronco pluripotentes |
| US20100028307A1 (en) * | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
| RU2522001C2 (ru) * | 2008-10-31 | 2014-07-10 | Сентокор Орто Байотек Инк. | Дифференцирование человеческих эмбриональных стволовых клеток в линию панкреатических эндокринных клеток |
| CA2768720C (en) * | 2009-07-20 | 2018-12-18 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| DK2499236T3 (da) * | 2009-11-12 | 2020-03-23 | Technion Res & Dev Foundation | Dyrkningsmedier, cellekulturer og metoder til dyrkning af pluripotente stamceller i en udifferentieret tilstand |
| US20120322152A1 (en) * | 2010-03-02 | 2012-12-20 | Michael Raghunath | Culture Additives To Boost Stem Cell Proliferation And Differentiation Response |
| CN103038336A (zh) * | 2010-03-23 | 2013-04-10 | 可乐丽股份有限公司 | 使多能性哺乳细胞分化的培养方法 |
| AU2011296383B2 (en) * | 2010-08-31 | 2016-03-10 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells |
-
2013
- 2013-05-07 JP JP2015511622A patent/JP6450674B2/ja not_active Expired - Fee Related
- 2013-05-07 RU RU2014149185A patent/RU2668814C2/ru not_active IP Right Cessation
- 2013-05-07 AU AU2013259706A patent/AU2013259706A1/en not_active Abandoned
- 2013-05-07 WO PCT/US2013/039940 patent/WO2013169769A1/en not_active Ceased
- 2013-05-07 KR KR1020147033897A patent/KR20150014478A/ko not_active Ceased
- 2013-05-07 MX MX2014013524A patent/MX2014013524A/es unknown
- 2013-05-07 SG SG11201406884SA patent/SG11201406884SA/en unknown
- 2013-05-07 US US13/888,968 patent/US20140162359A1/en not_active Abandoned
- 2013-05-07 CA CA2872770A patent/CA2872770A1/en not_active Abandoned
- 2013-05-07 HK HK15108511.6A patent/HK1207885A1/xx unknown
- 2013-05-07 BR BR112014027783A patent/BR112014027783A2/pt not_active Application Discontinuation
- 2013-05-07 CN CN201380024226.9A patent/CN104284977A/zh active Pending
- 2013-05-07 EP EP13786955.8A patent/EP2847319A4/en not_active Withdrawn
- 2013-05-07 AR ARP130101563A patent/AR090970A1/es unknown
-
2014
- 2014-10-14 IN IN8561DEN2014 patent/IN2014DN08561A/en unknown
- 2014-10-19 IL IL235132A patent/IL235132A0/en unknown
- 2014-12-02 PH PH12014502686A patent/PH12014502686A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2668814C2 (ru) | 2018-10-02 |
| IN2014DN08561A (enExample) | 2015-05-22 |
| WO2013169769A1 (en) | 2013-11-14 |
| MX2014013524A (es) | 2015-02-10 |
| AU2013259706A1 (en) | 2014-10-30 |
| KR20150014478A (ko) | 2015-02-06 |
| AR090970A1 (es) | 2014-12-17 |
| BR112014027783A2 (pt) | 2017-06-27 |
| EP2847319A4 (en) | 2015-12-16 |
| HK1207885A1 (en) | 2016-02-12 |
| CN104284977A (zh) | 2015-01-14 |
| JP2015516161A (ja) | 2015-06-11 |
| RU2014149185A (ru) | 2016-06-27 |
| IL235132A0 (en) | 2014-12-31 |
| SG11201406884SA (en) | 2014-11-27 |
| EP2847319A1 (en) | 2015-03-18 |
| US20140162359A1 (en) | 2014-06-12 |
| CA2872770A1 (en) | 2013-11-14 |
| JP6450674B2 (ja) | 2019-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014502686A1 (en) | Differentiation of human embryonic stem cells into pancreatic endoderm | |
| PH12013500389A1 (en) | Differentiation of human embryonic stem cells | |
| PH12014501429A1 (en) | Differentiation of human embryonic stem cells into single hormonal insulin positive cells | |
| PH12018501293A1 (en) | Differentiation of human embryonic stem cells into pancreatic endocrine cells | |
| PH12013500367A1 (en) | Differentiation of human embryonic stem cells | |
| PH12012502189B1 (en) | Differentiation of human embryonic stem cells | |
| GB2485112A (en) | Differentiation of human embryonic stem cells | |
| PH12015501477A1 (en) | Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells | |
| PH12013500349A1 (en) | Differentiation of pluripotent stem cells | |
| MX339669B (es) | Diferenciacion de celulas madres embrionarias humanas. | |
| MX2016005657A (es) | Suspensión y agrupamiento de células madre humanas pluripotentes para la diferenciación a células endocrinas pancreáticas. | |
| PH12015501450A1 (en) | Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators | |
| HK1217110A1 (zh) | 在空氣-液體界面處培養人胚胎幹細胞以用於分化成胰腺內分泌細胞 | |
| SG10201810739VA (en) | Use of small molecules to enhance mafa expression in pancreatic endocrine cells | |
| IL234095A0 (en) | Growth of mesenchymal stem cells in culture | |
| PH12014502748A1 (en) | Differentiation of human embryonic stem cells into pancreatic endocrine cells | |
| SG11201505965TA (en) | Culture method for stable undifferentiated proliferation of pluripotent stem cells | |
| PH12014501426A1 (en) | Induced pluripotent stem cells from human umbilical cord tissue-derived cells | |
| WO2012126013A3 (en) | Method for making pluripotent stem cells | |
| ZA201405320B (en) | Induced pluripotent stem cells prepared from human kidney-derived cells |